{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T23:22:33Z","timestamp":1787440953021,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001703","name":"\u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018694","name":"European Commission Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","award":["754354"],"award-info":[{"award-number":["754354"]}],"id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.biopha.2026.119580","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:02:50Z","timestamp":1779912170000},"page":"119580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Spheroid screening: A simplified model driving targeted drug discovery and clinical advances"],"prefix":"10.1016","volume":"200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9172-835X","authenticated-orcid":false,"given":"Irina L.","family":"Sinenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2575-1989","authenticated-orcid":false,"given":"Fabien","family":"Kuttler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kseniya","family":"Glinkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Turcatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Dyson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8928-1050","authenticated-orcid":false,"given":"Francis L.","family":"Munier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119580_bib1","doi-asserted-by":"crossref","unstructured":"Zushin P.J.H., Mukherjee S., Wu J.C. FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI\/ML-based approaches. J Clin Invest. 133(21):e175824. doi:10.1172\/JCI175824 PubMed PMID: 37909337; PubMed Central PMCID: PMC10617761.","DOI":"10.1172\/JCI175824"},{"issue":"9","key":"10.1016\/j.biopha.2026.119580_bib2","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.chembiol.2017.06.012","article-title":"Tumor organoids as a pre-clinical cancer model for drug Discovery","volume":"24","author":"Weeber","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.biopha.2026.119580_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101407","article-title":"3D patient-derived tumor models to recapitulate pediatric brain tumors In Vitro","volume":"20","author":"Tang-Schomer","year":"2022","journal-title":"Transl. Oncol."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2026.119580_bib4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","article-title":"A living biobank of breast cancer organoids captures disease heterogeneity","volume":"172","author":"Sachs","year":"2018","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.biopha.2026.119580_bib5","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s11517-022-02514-2","article-title":"A multi-layered hybrid model for cancer cell invasion","volume":"60","author":"Sadhukhan","year":"2022","journal-title":"Med Biol. Eng. Comput."},{"issue":"1","key":"10.1016\/j.biopha.2026.119580_bib6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/ijms23010122","article-title":"Bioprinted cancer model of neuroblastoma in a renal microenvironment as an efficiently applicable drug testing platform","volume":"23","author":"Wu","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119580_bib7","first-page":"1116","article-title":"Multicellular tumor spheroids of LNCaP-Luc prostate cancer cells as in vitro screening models for cytotoxic drugs","volume":"12","author":"Jouberton","year":"2022","journal-title":"Am. J. Cancer Res"},{"issue":"1","key":"10.1016\/j.biopha.2026.119580_bib8","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1038\/s41467-024-48010-z","article-title":"A vascularized breast cancer spheroid platform for the ranked evaluation of tumor microenvironment-targeted drugs by light sheet fluorescence microscopy","volume":"15","author":"Ascheid","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119580_bib9","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41467-021-21029-2","article-title":"3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels","volume":"12","author":"Daly","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119580_bib10","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/s41598-020-58569-4","article-title":"3D tumour spheroids for the prediction of the effects of radiation and hyperthermia treatments","volume":"10","author":"Br\u00fcningk","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2026.119580_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10911-016-9359-2","article-title":"Generation of multicellular breast cancer tumor spheroids: comparison of different protocols","volume":"21","author":"Froehlich","year":"2016","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"issue":"1","key":"10.1016\/j.biopha.2026.119580_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053708","article-title":"AlgiMatrix\u2122 Based 3D Cell culture system as an in-vitro tumor model for anticancer studies","volume":"8","author":"Godugu","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biopha.2026.119580_bib13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1109\/OJEMB.2022.3178302","article-title":"Assessment of CAR-T cell-mediated cytotoxicity in 3d microfluidic cancer co-culture models for combination therapy","volume":"3","author":"Paterson","year":"2022","journal-title":"IEEE Open J. Eng. Med Biol."},{"issue":"14","key":"10.1016\/j.biopha.2026.119580_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/ijms241411427","article-title":"Bioreactor technologies for enhanced organoid culture","volume":"24","author":"Licata","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119580_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.34133\/2022\/9809763","article-title":"Honeycomb-like hydrogel microspheres for 3d bulk construction of tumor models","volume":"2022","author":"He","year":"2022","journal-title":"Research"},{"issue":"FEB","key":"10.1016\/j.biopha.2026.119580_bib16","article-title":"vitro tumor models: Advantages, disadvantages, variables, and selecting the right platform","volume":"4","author":"Katt","year":"2016","journal-title":"Front Bioeng. Biotechnol."},{"key":"10.1016\/j.biopha.2026.119580_bib17","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1021\/acsbiomaterials.1c01536","article-title":"Developer\u2019s guide to an organ-on-chip model","volume":"8","author":"Rogal","year":"2022","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"3","key":"10.1016\/j.biopha.2026.119580_bib18","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"10207","key":"10.1016\/j.biopha.2026.119580_bib19","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2026.119580_bib20","first-page":"1","article-title":"Profiling the heterogeneity of colorectal cancer consensus molecular subtypes using spatial transcriptomics","volume":"8","author":"Valdeolivas","year":"2024","journal-title":"Npj Precis Oncol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119580_bib21","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/jgh.15937","article-title":"The emerging era of personalized medicine in advanced colorectal cancer","volume":"37","author":"Wu","year":"2022","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119580_bib22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.biopha.2026.119580_bib23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11912-023-01378-5","article-title":"Chemotherapy duration for various indications in colorectal cancer: a review","volume":"25","author":"Damato","year":"2023","journal-title":"Curr. Oncol. Rep."},{"issue":"14","key":"10.1016\/j.biopha.2026.119580_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/cancers16142597","article-title":"Chemotoxicity and associated risk factors in colorectal cancer: a systematic review and meta-analysis","volume":"16","author":"Han","year":"2024","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.biopha.2026.119580_bib25","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.3390\/cancers14122928","article-title":"Drug resistance in colorectal cancer: from mechanism to clinic","volume":"14","author":"Wang","year":"2022","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.biopha.2026.119580_bib26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: rationale, challenges and potential","volume":"16","author":"Ganesh","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119580_bib27","first-page":"1","article-title":"Retinoblastoma","volume":"1","author":"Dimaras","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"May","key":"10.1016\/j.biopha.2026.119580_bib28","article-title":"Conservative management of retinoblastoma: challenging orthodoxy without compromising the state of metastatic grace. \u201cAlive, with good vision and no comorbidity.\u201d","volume":"73","author":"Munier","year":"2019","journal-title":"Prog. Retin Eye Res"},{"issue":"April","key":"10.1016\/j.biopha.2026.119580_bib29","first-page":"1","article-title":"Treatment of retinoblastoma: what is the latest and what is the future","volume":"12","author":"Schaiquevich","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2026.119580_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2023.109447","article-title":"The predictive capacity of in vitro preclinical models to evaluate drugs for the treatment of retinoblastoma","volume":"230","author":"Sinenko","year":"2023","journal-title":"Exp. Eye Res"},{"key":"10.1016\/j.biopha.2026.119580_bib31","series-title":"Pediatric Nonclinical Drug Testing [Internet]","first-page":"59","article-title":"FDA Approach to Pediatric Testing","author":"Osterberg","year":"2012"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2026.119580_bib32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.drudis.2012.07.009","article-title":"Drug repurposing in pediatrics and pediatric hematology oncology","volume":"18","author":"Blatt","year":"2013","journal-title":"Drug Discov. Today"},{"issue":"8","key":"10.1016\/j.biopha.2026.119580_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007961","article-title":"Mathematical modelling reveals cellular dynamics within tumour spheroids","volume":"16","author":"Bull","year":"2020","journal-title":"PLOS Comput. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119580_bib34","doi-asserted-by":"crossref","first-page":"9751","DOI":"10.1038\/s41598-025-92037-1","article-title":"Influence of experimental variables on spheroid attributes","volume":"15","author":"Zhu","year":"2025","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.biopha.2026.119580_bib35","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1111\/cas.15878","article-title":"Translational screening platform to evaluate chemotherapy in combination with focal therapy for retinoblastoma","volume":"114","author":"Sinenko","year":"2023","journal-title":"Cancer Sci."},{"issue":"9","key":"10.1016\/j.biopha.2026.119580_bib36","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/s41551-020-0565-2","article-title":"High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays","volume":"4","author":"Brandenberg","year":"2020","journal-title":"Nat. Biomed. Eng."},{"issue":"8","key":"10.1016\/j.biopha.2026.119580_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pbc.27809","article-title":"Cancer drugs approved for use in children: Impact of legislative initiatives and future opportunities","volume":"66","author":"Barone","year":"2019","journal-title":"Pedia Blood Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119580_bib38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2174\/13862073113166660062","article-title":"Digital holographic microscopy: a quantitative label-free microscopy technique for phenotypic screening","volume":"17","author":"Rappaz","year":"2014","journal-title":"Comb. Chem. High. Throughput Screen"},{"issue":"6","key":"10.1016\/j.biopha.2026.119580_bib39","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00418-008-0536-2","article-title":"Chick embryo chorioallantoic membrane model systems to study and visualize human tumor cell metastasis","volume":"130","author":"Deryugina","year":"2008","journal-title":"Histochem Cell Biol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119580_bib40","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s10456-014-9440-7","article-title":"The chicken chorioallantoic membrane model in biology, medicine and bioengineering","volume":"17","author":"Nowak-Sliwinska","year":"2014","journal-title":"Angiogenesis"},{"issue":"7","key":"10.1016\/j.biopha.2026.119580_bib41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","article-title":"Organoids in cancer research","volume":"18","author":"Drost","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.biopha.2026.119580_bib42","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/s41416-020-0993-5","article-title":"Current concepts in tumour-derived organoids","volume":"123","author":"Porter","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.biopha.2026.119580_bib43","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","article-title":"Modeling development and disease with organoids","volume":"165","author":"Clevers","year":"2016","journal-title":"Cell"},{"issue":"6378","key":"10.1016\/j.biopha.2026.119580_bib44","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Vlachogiannis","year":"2018","journal-title":"Science"},{"issue":"513","key":"10.1016\/j.biopha.2026.119580_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay2574","article-title":"Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients","volume":"11","author":"Ooft","year":"2019","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.biopha.2026.119580_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1414311","article-title":"Organoids as a new approach for improving pediatric cancer research","volume":"14","author":"Lampis","year":"2024","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2026.119580_bib47","article-title":"Development of a cancer metastasis-on-chip assay for high throughput drug screening","volume":"13","author":"Ozer","year":"2023","journal-title":"Front Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119580_bib48","doi-asserted-by":"crossref","first-page":"7870","DOI":"10.1038\/s41598-022-11670-2","article-title":"Cell fiber-based 3D tissue array for drug response assay","volume":"12","author":"Kato-Negishi","year":"2022","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.biopha.2026.119580_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103817","article-title":"Multiplexing spheroid volume, resazurin and acid phosphatase viability assays for high-throughput screening of tumour spheroids and stem cell neurospheres","volume":"9","author":"Ivanov","year":"2014","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.biopha.2026.119580_bib50","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.3390\/cancers14081855","article-title":"Utilizing three-dimensional culture methods to improve high-throughput drug screening in anaplastic thyroid carcinoma","volume":"14","author":"Bergdorf","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.biopha.2026.119580_bib51","doi-asserted-by":"crossref","DOI":"10.1093\/biomethods\/bpae060","article-title":"Methods in cancer research: assessing therapy response of spheroid cultures by life cell imaging using a cost-effective live-dead staining protocol","volume":"9","author":"Phour","year":"2024","journal-title":"Biol. Methods Protoc."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:56:38Z","timestamp":1787439398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226006165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":51,"alternative-id":["S0753332226006165"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119580","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spheroid screening: A simplified model driving targeted drug discovery and clinical advances","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119580","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119580"}}